Drug name - Rasuvo
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8664231 | MEDEXUS | Concentrated methotrexate solutions |
Jun, 2029
(6 years from now) | |
Drugs and Companies using METHOTREXATE ingredient
Treatment: Subcutaneous injection of methotrexate
Dosage: SOLUTION;SUBCUTANEOUS
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 7.5MG/0.15ML (7.5MG/0.15ML) | SOLUTION;SUBCUTANEOUS | Prescription |
| 10MG/0.20ML (10MG/0.20ML) | SOLUTION;SUBCUTANEOUS | Prescription |
| 12.5MG/0.25ML (12.5MG/0.25ML) | SOLUTION;SUBCUTANEOUS | Prescription |
| 15MG/0.30ML (15MG/0.30ML) | SOLUTION;SUBCUTANEOUS | Prescription |
| 17.5MG/0.35ML (17.5MG/0.35ML) | SOLUTION;SUBCUTANEOUS | Prescription |
| 20MG/0.4ML (20MG/0.4ML) | SOLUTION;SUBCUTANEOUS | Prescription |
| 22.5MG/0.45ML (22.5MG/0.45ML) | SOLUTION;SUBCUTANEOUS | Prescription |
| 25MG/0.5ML (25MG/0.5ML) | SOLUTION;SUBCUTANEOUS | Prescription |
| 27.5MG/0.55ML (27.5MG/0.55ML) | SOLUTION;SUBCUTANEOUS | Discontinued |
| 30MG/0.6ML (30MG/0.6ML) | SOLUTION;SUBCUTANEOUS | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.